Robert Morgan

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (11)

Richard Unwin

The University of Manchester

UNITED KINGDOM

View details

Richard Edmondson

The University of Manchester

UNITED KINGDOM

View details

rosa legood

Associate Professor

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

Richard Adams

Professor

Cardiff University

UNITED KINGDOM

View details

Nicola Flaum

The University of Manchester

UNITED KINGDOM

View details

Gareth Evans

The University of Manchester

UNITED KINGDOM

View details

Gordon Jayson

The University of Manchester

UNITED KINGDOM

View details

Claire Mitchell

The University of Manchester

UNITED KINGDOM

View details

Emma Woodward

Manchester University NHS Foundation Trust

UNITED KINGDOM

View details

Barbara Norquist

Assistant Professor

University of Washington

UNITED STATES

View details

Angela Casbard

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Morgan

Research Interests

Explore related searches

Contact this professor

Articles (10)

Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma.

Smoking Adversely Affects Survival of Metastatic Lung Carcinoid Patients: Analysis of a Large International Audit and Prognostic Models for Metastasis-Free Survival and Overall Survival.

Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancer

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial

Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer

Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation

Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer.

Real-World Concordance between Germline and Tumour <i>BRCA1/2</i> Status in Epithelial Ovarian Cancer

Collaborators (11)

Richard Unwin

Richard Edmondson

rosa legood

Richard Adams

Nicola Flaum

Gareth Evans

Gordon Jayson

Claire Mitchell

Emma Woodward

Barbara Norquist

Angela Casbard

Make your next move.